Automated Breast Ultrasound Systems Market By Product Type (Ultrasound System and Ultrasound Scanner), By Application (Radiology, Oncology, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2033

Report Overview

The Automated Breast Ultrasound Systems Market size is expected to be worth around US$ 4.8 billion by 2034 from US$ 1.9 billion in 2024, growing at a CAGR of 9.7% during the forecast period 2025 to 2034.

Increasing awareness of the importance of early breast cancer detection and the growing focus on non-invasive diagnostic methods are driving the growth of the automated breast ultrasound systems market. These systems provide a valuable supplement to mammography, offering detailed images of breast tissue and enabling the identification of abnormalities that may be difficult to detect with traditional methods, particularly in women with dense breast tissue.

Rising rates of breast cancer diagnoses contribute to the market expansion, as early and accurate detection is critical to improving patient outcomes. In March 2024, the World Health Organization (WHO) reported that in 2022, around 2.3 million women worldwide were diagnosed with breast cancer, with the disease resulting in approximately 670,000 deaths. This highlights the urgent need for enhanced screening technologies.

Recent trends in the market include the increasing adoption of automated breast ultrasound systems, which offer higher efficiency and consistency in detecting tumors, particularly in high-risk patients. Innovations in the technology, such as the integration of artificial intelligence (AI) for image analysis, further enhance diagnostic accuracy and workflow efficiency.

Additionally, the growing demand for personalized medicine and the rising number of women seeking preventive screenings present significant opportunities for the market. As these systems become more accessible and affordable, automated breast ultrasound systems are poised to play a key role in improving breast cancer diagnosis and care worldwide.

Key Takeaways

• In 2023, the market for Automated Breast Ultrasound Systems generated a revenue of US$ 1.9 billion, with a CAGR of 9.7%, and is expected to reach US$ 4.8 billion by the year 2033.
• The product type segment is divided into ultrasound system and ultrasound scanner, with ultrasound system taking the lead in 2023 with a market share of 62.5%.
• Considering application, the market is divided into radiology, oncology, and others. Among these, oncology held a significant share of 48.7%.
• North America led the market by securing a market share of 40.3% in 2023.

Product Type Analysis

The ultrasound system segment led in 2023, claiming a market share of 62.5% owing to the increasing demand for efficient and accurate diagnostic tools in breast cancer detection. The integration of advanced ultrasound systems with automated technology is anticipated to improve the speed, precision, and reliability of breast examinations. These systems allow for quicker screening of large volumes of patients and reduce human error, making them especially beneficial in busy clinical environments.

The ability of automated systems to detect subtle changes in tissue, such as early-stage tumors, is expected to enhance early diagnosis, which is crucial for effective treatment. As healthcare providers continue to prioritize non-invasive methods and patient comfort, the ultrasound system segment in this market is projected to grow significantly.

Application Analysis

The oncology segment dominated the market, holding a significant 48.7% share. This prominence is attributed to the rising incidence of breast cancer and the urgent need for its early detection. Automated breast ultrasound systems are becoming essential in spotting malignancies not visible in traditional mammograms. These systems are particularly valuable for women with dense breast tissue, enhancing diagnostic accuracy and streamlining screening processes.

The adoption of advanced imaging technologies in oncology is expected to increase, driven by a focus on early cancer detection and personalized treatment plans. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms is set to further boost the capabilities of these systems. This technological advancement supports the growth of the oncology segment by improving diagnostic precision and efficiency.

Key Market Segments

By Product Type

• Ultrasound System
• Ultrasound Scanner

By Application

• Radiology
• Oncology
• Others

Drivers

Growing Prevalence of Cancer Driving the Automated Breast Ultrasound Systems Market

Rising cancer prevalence is anticipated to drive the automated breast ultrasound systems market, as early detection remains crucial for improving survival rates. A 2023 report from the American Cancer Society estimated that approximately 1.9 million individuals were diagnosed with cancer that year, emphasizing the need for advanced imaging technologies.

Automated breast ultrasound systems provide enhanced detection capabilities, particularly for women with dense breast tissue, where traditional mammograms may be less effective. These systems improve diagnostic accuracy by capturing comprehensive 3D breast images, reducing the likelihood of missed tumors. The integration of AI-driven algorithms enhances image analysis, offering radiologists improved diagnostic confidence.

Growing awareness campaigns are encouraging more women to undergo routine breast screenings, increasing the demand for reliable imaging solutions. Hospitals and diagnostic centers are investing in automated technologies to streamline workflows and optimize patient outcomes. Technological advancements are leading to more compact and portable ultrasound devices, expanding accessibility to remote and underserved regions.

Increased government funding for breast cancer research is supporting the adoption of innovative imaging modalities. Partnerships between medical device manufacturers and healthcare institutions are accelerating product development and commercialization. These factors collectively contribute to the expansion of automated breast ultrasound systems in the diagnostic imaging landscape.

Restraints

High Costs Are Restraining the Automated Breast Ultrasound Systems Market

High costs are restraining the automated breast ultrasound systems market, limiting adoption among smaller healthcare facilities. The initial investment required for purchasing and installing these systems is significantly higher compared to traditional mammography or handheld ultrasound devices. Maintenance and software updates add ongoing financial burdens, making affordability a challenge for budget-constrained hospitals.

Insurance coverage for automated ultrasound screenings remains inconsistent, creating uncertainty for both providers and patients regarding reimbursement policies. Training requirements for radiologists and technicians increase operational costs, as specialized knowledge is needed to interpret 3D imaging results accurately.

Limited access to advanced imaging infrastructure in low-income regions further restricts market penetration. High research and development costs associated with improving system accuracy and integrating AI further elevate device prices. Addressing these cost barriers through government subsidies and flexible financing options could help expand market reach.

Opportunities

Increasing Extensive R&D as an Opportunity for the Automated Breast Ultrasound Systems Market

Growing investment in R&D is projected to create opportunities for the automated breast ultrasound systems market by improving imaging capabilities and expanding diagnostic applications. A study published by the Massachusetts Institute of Technology (MIT) in July 2023 detailed the development of a wearable ultrasound device designed to detect breast tumors at an early stage, potentially improving survival rates.

Researchers are leveraging AI and machine learning to enhance image interpretation, reducing false positives and improving diagnostic precision. Advancements in ultrasound transducer technology are enabling clearer and more detailed breast tissue visualization. The development of portable and wireless automated ultrasound systems is increasing accessibility, particularly in rural healthcare settings.

Government initiatives supporting breast cancer research and early detection programs are fostering innovation in ultrasound imaging. Collaborations between biotech firms and academic institutions are accelerating the translation of research findings into commercial products. These R&D efforts are expected to enhance the efficiency and affordability of automated breast ultrasound systems, driving market expansion.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors significantly impact the automated breast ultrasound systems market. On the positive side, rising healthcare investments and government initiatives to improve cancer screening services, particularly in emerging economies, drive the demand for advanced diagnostic tools. The global push for early detection of breast cancer further boosts the need for efficient and accessible imaging technologies. However, economic downturns and budget cuts in healthcare spending can hinder the adoption of high-cost technologies in public health systems.

Geopolitical tensions, trade barriers, and regulatory differences between countries may disrupt the availability of medical devices, delaying the rollout of automated breast ultrasound systems. Supply chain disruptions, rising material costs, and uncertainties around international trade policies could also impact production and delivery timelines. Despite these challenges, the increasing global focus on improving healthcare access, coupled with technological advancements in diagnostic imaging, ensures a positive growth trajectory for the market.

Trends

Incorporation of AI Driving the Automated Breast Ultrasound Systems Market

Increasing incorporation of artificial intelligence (AI) is a key trend driving the automated breast ultrasound systems market. High demand for more accurate, efficient, and user-friendly diagnostic tools is expected to accelerate the integration of AI in imaging systems. AI enhances the interpretation of ultrasound images, reducing diagnostic errors and enabling faster, more precise assessments.

The ability to automate and optimize image analysis is projected to significantly improve workflow efficiency and consistency in clinical settings. AI-powered systems are likely to make breast cancer detection more accessible and affordable by enabling better utilization of resources, particularly in remote or underserved areas.

In February 2023, Abdul Latif Jameel Health partnered with iSono Health to introduce a portable 3D ultrasound scanner designed for breast imaging. The device incorporates AI-driven automation, providing high-quality imaging while improving accessibility for early cancer detection. As AI continues to evolve, its integration into automated breast ultrasound systems is anticipated to drive further innovation, expanding the market’s reach and adoption.

Regional Analysis

North America is leading the Automated Breast Ultrasound Systems Market

North America dominated the market with the highest revenue share of 40.3% owing to increasing breast cancer cases and advancements in imaging technology. iSono Health’s FDA clearance for the ATUSA System in May 2022 played a crucial role in improving the efficiency and accuracy of breast cancer detection. The rising awareness of early diagnosis and screening programs encouraged healthcare providers to adopt automated solutions for more precise imaging, particularly for women with dense breast tissue.

Technological innovations, including AI-powered analysis and real-time 3D imaging, enhanced diagnostic accuracy and workflow efficiency. Expanding healthcare infrastructure and favorable reimbursement policies supported the widespread adoption of these systems across hospitals and imaging centers. The growing prevalence of breast cancer in the U.S. and Canada further fueled demand for advanced diagnostic tools.

Collaborations between medical device manufacturers and research institutions accelerated the development of improved screening solutions. Additionally, government initiatives promoting breast cancer awareness and funding for advanced imaging technologies contributed to market expansion.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

Asia Pacific is expected to grow with the fastest CAGR owing to increasing breast cancer incidence and rising investment in healthcare infrastructure. Expanding access to diagnostic services in countries like China, India, and Japan is expected to improve screening rates, particularly in underserved areas. Government programs promoting early breast cancer detection are likely to support the adoption of advanced imaging technologies.

Collaborations between global medical device companies and regional healthcare providers are projected to enhance product availability and affordability. Technological advancements, including AI-driven imaging and portable ultrasound solutions, are expected to boost market penetration. Growing awareness campaigns and educational initiatives about breast cancer screening are anticipated to drive demand.

Increasing medical tourism, particularly in countries offering cost-effective and high-quality diagnostic services, is likely to attract more patients seeking advanced imaging solutions. Rising healthcare expenditures and private sector investments in diagnostic innovation are projected to further strengthen market growth across Asia Pacific.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

Key players in the automated breast ultrasound systems market focus on enhancing imaging accuracy and workflow efficiency to improve early breast cancer detection. Companies invest in research and development to integrate artificial intelligence, 3D imaging, and automated scanning capabilities for better diagnostic outcomes. Strategic partnerships with hospitals and diagnostic centers help expand market reach and increase adoption among radiologists.

Geographic expansion into regions with rising breast cancer incidence supports further growth. Many players also prioritize affordability and user-friendly designs to encourage widespread use in routine screenings. GE Healthcare is a leading company in this market, offering advanced solutions like the Invenia ABUS 2.0, which provides high-resolution 3D images for improved breast cancer detection.

The company focuses on innovation and collaboration with healthcare providers to enhance diagnostic accuracy and accessibility. GE Healthcare’s commitment to advancing ultrasound technology and expanding global adoption establishes it as a key player in the industry.

Recent Developments

• In October 2023, GE Healthcare reported that its Invenia ABUS 2.0 system has enhanced breast cancer detection through advanced 3D ultrasound technology and AI-driven analysis. This innovation allows radiologists to examine dense breast tissue more effectively, improving the identification of small, invasive tumors often missed by traditional mammography.
• In July 2024, Delphinus Medical Technologies, Inc. deployed its SoftVue breast ultrasound tomography system at West Jefferson Medical Center in Louisiana, offering patients an advanced imaging solution for more precise breast cancer screening.

Top Key Players in the Automated Breast Ultrasound Systems Market

• XEROX
• Siemens Healthineers
• Koninklijke Philips
• GE Healthcare
• FUJIFILM Holdings
• Carestream Health
• Delphinus Medical Technologies, Inc
• Acuson

Report Scope